This new report provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin. During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=99743.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/2013-therapeutic-drug-monitoring-tdm-market-in-france-hospitals-and-commercial-labs-market-report.html.
No comments:
Post a Comment